Dark Forest Capital Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,502
Closed -$265K 1148
2025
Q3
$265K Sell
18,502
-151,723
-89% -$2.08M 0.01% 1050
2025
Q2
$2.09M Buy
170,225
+154,109
+956% +$2.24M 0.08% 428
2025
Q1
$354K Sell
16,116
-830
-5% -$19.5K 0.02% 1021
2024
Q4
$384K Sell
16,946
-40,500
-71% -$884K 0.06% 554
2024
Q3
$1.04M Buy
57,446
+43,848
+322% +$1.02M 0.13% 161
2024
Q2
$396K Sell
13,598
-137,495
-91% -$4.08M 0.07% 346
2024
Q1
$5.36M Buy
151,093
+146,118
+2,937% +$5.84M 0.91% 12
2023
Q4
$217K Sell
4,975
-3,466
-41% -$136K 0.03% 382
2023
Q3
$322K Sell
8,441
-9,107
-52% -$383K 0.02% 880
2023
Q2
$722K Buy
+17,548
New +$845K 0.07% 453
2022
Q4
Sell
-146
Closed -$6K 1302
2022
Q3
$6K Buy
146
+130
+813% +$6.66K ﹤0.01% 846
2022
Q2
$1K Buy
+16
New +$961 ﹤0.01% 791
2022
Q1
Sell
-203
Closed -$14K 1503
2021
Q4
$14K Sell
203
-59
-23% -$3.99K 0.01% 801
2021
Q3
$18K Sell
262
-627
-71% -$44.3K 0.01% 846
2021
Q2
$61K Buy
+889
New +$62.9K 0.03% 418

Other funds holding IART

Dark Forest Capital Management's IART Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 18,502 shares — an estimated $265K sold.

Dark Forest Capital Management first reported a position in IART in Q2 2021 and held it in 15 quarters. The position peaked at $5.36M in Q1 2024. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • Dark Forest Capital Management reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 18,502 Integra LifeSciences shares in Q4 2025, an estimated $265K.
  • Dark Forest Capital Management first reported a position in Integra LifeSciences in Q2 2021 and held it in 15 quarters.
  • Dark Forest Capital Management's Integra LifeSciences position peaked at $5.36M in Q1 2024.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.